NCT07115043 A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07049926 Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03) Status RECRUITING Phase PHASE1/PHASE2
NCT07018037 Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma Status RECRUITING Phase N/A
NCT07011849 Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases Status WITHDRAWN Phase PHASE2
NCT06995664 Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management Status RECRUITING Phase NA
NCT06966024 Study of DCC-2812 in Participants With Advanced Genitourinary Cancers Status RECRUITING Phase PHASE1
NCT06860386 Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC Status SUSPENDED Phase PHASE2
NCT06770855 Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC) Status NOT_YET_RECRUITING Phase NA
NCT06699602 A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06682793 A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT06586658 Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells Status RECRUITING Phase EARLY_PHASE1
NCT06585878 A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma Status NOT_YET_RECRUITING Phase NA
NCT06582017 Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma Status RECRUITING Phase PHASE1
NCT06580938 A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer Status TERMINATED Phase PHASE1
NCT06577961 Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06546553 A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. Status TERMINATED Phase PHASE1
NCT06536439 Planning Operative Strategy Using a Digital Renal Artery Clamping Tool Status RECRUITING Phase NA
NCT06523049 Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy Status NOT_YET_RECRUITING Phase PHASE2